Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway

References

• Apel K, Hirt H. 2004. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol. 55(1):373–399.
   PubMed Web of Science ®Google Scholar
• Cai Z, Hou S, Li Y, Zhao B, Yang Z, Xu S, Pu J. 2008. Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target. 16(2):178–184.
   PubMed Web of Science ®Google Scholar
• Cao W, Li X, Zheng S, Zheng W, Wong YS, Chen T. 2014. Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk. Oncotarget. 5(17):7431–7445.
   PubMedGoogle Scholar
• Chen J, Li L, Su J, Chen T. 2015. Natural borneol enhances bisdemethoxycurcumin-induced cell cycle arrest in the G2/M phase through up-regulation of intracellular ROS in HepG2 cells. Food Funct. 6(3):740–748.
   PubMed Web of Science ®Google Scholar
• Chen J, Li L, Su J, Li B, Chen T, Wong YS. 2014. Synergistic apoptosis-inducing effects on A375 human melanoma cells of natural borneol and curcumin. PLoS One. 9(6):e101277.
   PubMed Web of Science ®Google Scholar
• Chen J, Li L, Su J, Li B, Zhang X, Chen T. 2015. Proteomic analysis of G2/M arrest triggered by natural borneol/curcumin in HepG2 cells, the importance of the reactive oxygen species-p53 pathway. J Agric Food Chem. 63(28):6440–6449.
   PubMed Web of Science ®Google Scholar
• Duan M, Xing Y, Guo J, Chen H, Zhang R. 2016. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins. Pharm Biol. 54(12):3009–3018.
   PubMed Web of Science ®Google Scholar
• Gong S, Chen Y, Meng F, Zhang Y, Li C, Zhang G, Huan W, Wu F. 2018. Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis. Cell Prolif. 51(5):e12474.
   PubMed Web of Science ®Google Scholar
• Huse JT, Holland EC. 2010. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer. 10(5):319–331.
   PubMed Web of Science ®Google Scholar
• Lipinska N, Romaniuk A, Paszel-Jaworska A, Toton E, Kopczynski P, Rubis B. 2017. Telomerase and drug resistance in cancer. Cell Mol Life Sci. 74(22):4121–4132.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Yin YB, Sun JY, Feng S, Ma JK, Fu XY, Hou YJ, Yang MF, Sun BL, Fan CD. 2018. Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage. Onco Targets Ther. 11:5429–5439.
   PubMed Web of Science ®Google Scholar
• Lloyd DR, Phillips DH, Carmichael PL. 1997. Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem Res Toxicol. 10(4):393–400.
   PubMed Web of Science ®Google Scholar
• Meng X, Dong X, Wang W, Yang L, Zhang X, Li Y, Chen T, Ma H, Qi D, Su J. 2018. Natural borneol enhances paclitaxel-induced apoptosis of ESCC cells by inactivation of the PI3K/AKT. J Food Sci. 83(5):1436–1443.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Yano T, Shimokawa M, Takeo S, Yamazaki K, Sugio K, Takenoyama M, Nagashima A, Tsukamoto S, Hamatake M, et al. 2018. A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer. Lung Cancer. 124:255–259.
   PubMed Web of Science ®Google Scholar
• Pelicano H, Carney D, Huang P. 2004. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 7(2):97–110.
   PubMed Web of Science ®Google Scholar
• Qi HP, Gao XC, Zhang LQ, Wei SQ, Bi S, Yang ZC, Cui H. 2013. In vitro evaluation of enhancing effect of borneol on transcorneal permeation of compounds with different hydrophilicities and molecular sizes. Eur J Pharmacol. 705(1–3):20–25.
   PubMed Web of Science ®Google Scholar
• Rocha CR, Garcia CC, Vieira DB, Quinet A, de Andrade-Lima LC, Munford V, Belizario JE, Menck CF. 2015. Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. Cell Death Dis. 6(4):e1727.
   PubMedGoogle Scholar
• Schaff LR, Lassman AB. 2015. Indications for treatment: is observation or chemotherapy alone a reasonable approach in the management of low-grade gliomas? Semin Radiat Oncol. 25(3):203–209.
   PubMed Web of Science ®Google Scholar
• Sprauten M, Darrah TH, Peterson DR, Campbell ME, Hannigan RE, Cvancarova M, Beard C, Haugnes HS, Fossa SD, Oldenburg J, et al. 2012. Impact of long-term serum platinum concentrations on neuro- and ototoxicity in cisplatin-treated survivors of testicular cancer. JCO. 30(3):300–307.
   PubMed Web of Science ®Google Scholar
• Su J, Lai H, Chen J, Li L, Wong YS, Chen T, Li X. 2013. Natural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage. PLoS One. 8(5):e63502
   PubMed Web of Science ®Google Scholar
• Wandee J, Prawan A, Senggunprai L, Kongpetch S, Kukongviriyapan V. 2019. Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway. Life Sci. 217:155–163.
   PubMed Web of Science ®Google Scholar
• Wijdeven RH, Pang B, Assaraf YG, Neefjes J. 2016. Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics. Drug Resist Updat. 28:65–81.
   PubMed Web of Science ®Google Scholar
• Wu J, Xie J, Zhang QL, Lin ZX, Xie H, Sun B. 2016. [Research progress on meridian-guiding theory of traditional Chinese medicine]. Zhongguo Zhong Yao Za Zhi. 41(13):2428–2434.
   PubMedGoogle Scholar
• Xing YM, Yan XN, Guo JQ, Zhang R. 2016. Effect of borneol on the permeability of blood tumor barrier model and its mechanism study. Zhongguo Zhong Xi Yi Jie He Za Zhi. 36(6):696–702.
   PubMedGoogle Scholar
• Zhang Y, Zheng S, Zheng JS, Wong KH, Huang Z, Ngai SM, Zheng W, Wong YS, Chen T. 2014. Synergistic induction of apoptosis by methylseleninic acid and cisplatin, the role of ROS-ERK/AKT-p53 pathway. Mol Pharmaceutics. 11(4):1282–1293.
   PubMed Web of Science ®Google Scholar
• Zhou YD, Hou JG, Yang G, Jiang S, Chen C, Wang Z, Liu YY, Ren S, Li W. 2019. Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway. Biomed Pharmacother. 109:2309–2317.
   PubMed Web of Science ®Google Scholar